Eli Lilly (LLY) earnings Q4 2025

Health

Eli Lilly (Lly) Earnings Q4 2025

By CNBC

Eli Lilly on Wednesday posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soars. The pharmaceutical giant anticipates its 2026 ...Read more